Quest PharmaTech Inc.
QPTFF
$0.0133
-$0.0017-11.33%
OTC PK
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 47.67% | -56.08% | -64.10% | 4,160.34% | -33.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 55.85% | -71.26% | -41.85% | 62.07% | 2.22% |
| Operating Income | -55.85% | 71.26% | 41.85% | -62.07% | -2.22% |
| Income Before Tax | 104.54% | 507.05% | -704.56% | 123.20% | 18.24% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 104.54% | 507.05% | -704.56% | 123.20% | 18.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 104.54% | 507.05% | -704.56% | 123.20% | 18.24% |
| EBIT | -55.85% | 71.26% | 41.85% | -62.07% | -2.22% |
| EBITDA | -55.33% | 71.25% | 42.14% | -62.38% | -2.40% |
| EPS Basic | 106.06% | 487.50% | -660.00% | 122.95% | 19.51% |
| Normalized Basic EPS | 66.67% | 280.00% | -633.33% | -5.88% | 38.24% |
| EPS Diluted | 106.06% | 487.50% | -660.00% | 122.95% | 19.51% |
| Normalized Diluted EPS | 66.67% | 280.00% | -633.33% | -5.88% | 38.24% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 1.08% | 0.09% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 1.08% | 0.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |